nodes	percent_of_prediction	percent_of_DWPC	metapath
Busulfan—GSTA1—liver cancer	0.288	0.384	CbGaD
Busulfan—GSTA2—liver cancer	0.224	0.3	CbGaD
Busulfan—GSTM1—liver cancer	0.123	0.164	CbGaD
Busulfan—GSTP1—liver cancer	0.114	0.152	CbGaD
Busulfan—GSTA1—gall bladder—liver cancer	0.00411	0.207	CbGeAlD
Busulfan—GSTA2—gall bladder—liver cancer	0.00297	0.149	CbGeAlD
Busulfan—GSTA1—embryo—liver cancer	0.00261	0.131	CbGeAlD
Busulfan—GSTP1—gall bladder—liver cancer	0.0019	0.096	CbGeAlD
Busulfan—GSTA2—embryo—liver cancer	0.00188	0.0948	CbGeAlD
Busulfan—MGST2—liver—liver cancer	0.00142	0.0714	CbGeAlD
Busulfan—GSTP1—embryo—liver cancer	0.00121	0.0608	CbGeAlD
Busulfan—GSTA1—liver—liver cancer	0.0012	0.0607	CbGeAlD
Busulfan—GSTM1—liver—liver cancer	0.000891	0.0449	CbGeAlD
Busulfan—GSTA2—liver—liver cancer	0.000869	0.0438	CbGeAlD
Busulfan—GSTP1—liver—liver cancer	0.000558	0.0281	CbGeAlD
Busulfan—CYP3A4—liver—liver cancer	0.000228	0.0115	CbGeAlD
Busulfan—Blood uric acid increased—Doxorubicin—liver cancer	0.000203	0.00195	CcSEcCtD
Busulfan—Aplastic anaemia—Epirubicin—liver cancer	0.000202	0.00195	CcSEcCtD
Busulfan—Skin disorder—Sorafenib—liver cancer	0.000202	0.00194	CcSEcCtD
Busulfan—Hiccups—Doxorubicin—liver cancer	0.000199	0.00192	CcSEcCtD
Busulfan—Anorexia—Sorafenib—liver cancer	0.000198	0.00191	CcSEcCtD
Busulfan—Oesophagitis—Epirubicin—liver cancer	0.000197	0.0019	CcSEcCtD
Busulfan—Coma—Epirubicin—liver cancer	0.000197	0.0019	CcSEcCtD
Busulfan—Rash maculo-papular—Epirubicin—liver cancer	0.000195	0.00189	CcSEcCtD
Busulfan—Neoplasm—Epirubicin—liver cancer	0.000194	0.00188	CcSEcCtD
Busulfan—Bladder pain—Epirubicin—liver cancer	0.000194	0.00188	CcSEcCtD
Busulfan—Cystitis noninfective—Doxorubicin—liver cancer	0.000194	0.00187	CcSEcCtD
Busulfan—Cystitis—Doxorubicin—liver cancer	0.000192	0.00185	CcSEcCtD
Busulfan—Pulmonary oedema—Epirubicin—liver cancer	0.000191	0.00185	CcSEcCtD
Busulfan—Skin exfoliation—Doxorubicin—liver cancer	0.00019	0.00183	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000189	0.00182	CcSEcCtD
Busulfan—Blood urea increased—Doxorubicin—liver cancer	0.000188	0.00181	CcSEcCtD
Busulfan—Aplastic anaemia—Doxorubicin—liver cancer	0.000187	0.0018	CcSEcCtD
Busulfan—Sepsis—Epirubicin—liver cancer	0.000187	0.0018	CcSEcCtD
Busulfan—Dyspnoea—Sorafenib—liver cancer	0.000185	0.00178	CcSEcCtD
Busulfan—Dyspepsia—Sorafenib—liver cancer	0.000183	0.00176	CcSEcCtD
Busulfan—Coma—Doxorubicin—liver cancer	0.000182	0.00175	CcSEcCtD
Busulfan—Oesophagitis—Doxorubicin—liver cancer	0.000182	0.00175	CcSEcCtD
Busulfan—Rash maculo-papular—Doxorubicin—liver cancer	0.000181	0.00174	CcSEcCtD
Busulfan—Decreased appetite—Sorafenib—liver cancer	0.00018	0.00174	CcSEcCtD
Busulfan—Neoplasm—Doxorubicin—liver cancer	0.00018	0.00173	CcSEcCtD
Busulfan—Bladder pain—Doxorubicin—liver cancer	0.00018	0.00173	CcSEcCtD
Busulfan—Gastrointestinal disorder—Sorafenib—liver cancer	0.000179	0.00173	CcSEcCtD
Busulfan—Fatigue—Sorafenib—liver cancer	0.000179	0.00173	CcSEcCtD
Busulfan—Pain—Sorafenib—liver cancer	0.000178	0.00171	CcSEcCtD
Busulfan—Constipation—Sorafenib—liver cancer	0.000178	0.00171	CcSEcCtD
Busulfan—Pulmonary oedema—Doxorubicin—liver cancer	0.000177	0.00171	CcSEcCtD
Busulfan—Sepsis—Doxorubicin—liver cancer	0.000173	0.00167	CcSEcCtD
Busulfan—Gastrointestinal pain—Sorafenib—liver cancer	0.00017	0.00164	CcSEcCtD
Busulfan—Hot flush—Epirubicin—liver cancer	0.000167	0.00161	CcSEcCtD
Busulfan—Menopausal symptoms—Epirubicin—liver cancer	0.000165	0.0016	CcSEcCtD
Busulfan—Dermatitis exfoliative—Epirubicin—liver cancer	0.000165	0.0016	CcSEcCtD
Busulfan—Urticaria—Sorafenib—liver cancer	0.000165	0.00159	CcSEcCtD
Busulfan—Abdominal pain—Sorafenib—liver cancer	0.000164	0.00158	CcSEcCtD
Busulfan—Body temperature increased—Sorafenib—liver cancer	0.000164	0.00158	CcSEcCtD
Busulfan—Renal impairment—Epirubicin—liver cancer	0.000164	0.00158	CcSEcCtD
Busulfan—Dermatitis bullous—Epirubicin—liver cancer	0.000163	0.00158	CcSEcCtD
Busulfan—Lethargy—Epirubicin—liver cancer	0.000159	0.00154	CcSEcCtD
Busulfan—Hyponatraemia—Epirubicin—liver cancer	0.000157	0.00151	CcSEcCtD
Busulfan—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000156	0.00151	CcSEcCtD
Busulfan—Hot flush—Doxorubicin—liver cancer	0.000154	0.00149	CcSEcCtD
Busulfan—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000153	0.00148	CcSEcCtD
Busulfan—Menopausal symptoms—Doxorubicin—liver cancer	0.000153	0.00148	CcSEcCtD
Busulfan—Hypersensitivity—Sorafenib—liver cancer	0.000153	0.00148	CcSEcCtD
Busulfan—Renal impairment—Doxorubicin—liver cancer	0.000152	0.00146	CcSEcCtD
Busulfan—Dermatitis bullous—Doxorubicin—liver cancer	0.000151	0.00146	CcSEcCtD
Busulfan—Asthenia—Sorafenib—liver cancer	0.000149	0.00144	CcSEcCtD
Busulfan—Lethargy—Doxorubicin—liver cancer	0.000147	0.00142	CcSEcCtD
Busulfan—Pruritus—Sorafenib—liver cancer	0.000147	0.00142	CcSEcCtD
Busulfan—Blood creatinine increased—Epirubicin—liver cancer	0.000146	0.00141	CcSEcCtD
Busulfan—Hyponatraemia—Doxorubicin—liver cancer	0.000145	0.0014	CcSEcCtD
Busulfan—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000144	0.00139	CcSEcCtD
Busulfan—Hypokalaemia—Epirubicin—liver cancer	0.000142	0.00137	CcSEcCtD
Busulfan—Diarrhoea—Sorafenib—liver cancer	0.000142	0.00137	CcSEcCtD
Busulfan—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000141	0.00136	CcSEcCtD
Busulfan—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000138	0.00133	CcSEcCtD
Busulfan—Dizziness—Sorafenib—liver cancer	0.000137	0.00132	CcSEcCtD
Busulfan—Abdominal distension—Epirubicin—liver cancer	0.000136	0.00131	CcSEcCtD
Busulfan—Blood creatinine increased—Doxorubicin—liver cancer	0.000135	0.0013	CcSEcCtD
Busulfan—Asthma—Epirubicin—liver cancer	0.000135	0.0013	CcSEcCtD
Busulfan—Pancreatitis—Epirubicin—liver cancer	0.000132	0.00128	CcSEcCtD
Busulfan—Vomiting—Sorafenib—liver cancer	0.000132	0.00127	CcSEcCtD
Busulfan—Hypokalaemia—Doxorubicin—liver cancer	0.000131	0.00127	CcSEcCtD
Busulfan—Rash—Sorafenib—liver cancer	0.000131	0.00126	CcSEcCtD
Busulfan—Dermatitis—Sorafenib—liver cancer	0.000131	0.00126	CcSEcCtD
Busulfan—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00013	0.00125	CcSEcCtD
Busulfan—Headache—Sorafenib—liver cancer	0.00013	0.00125	CcSEcCtD
Busulfan—Pancytopenia—Epirubicin—liver cancer	0.000128	0.00124	CcSEcCtD
Busulfan—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000127	0.00123	CcSEcCtD
Busulfan—Neutropenia—Epirubicin—liver cancer	0.000126	0.00122	CcSEcCtD
Busulfan—Dysuria—Epirubicin—liver cancer	0.000126	0.00122	CcSEcCtD
Busulfan—Abdominal distension—Doxorubicin—liver cancer	0.000126	0.00121	CcSEcCtD
Busulfan—Asthma—Doxorubicin—liver cancer	0.000125	0.0012	CcSEcCtD
Busulfan—Nausea—Sorafenib—liver cancer	0.000123	0.00119	CcSEcCtD
Busulfan—Weight increased—Epirubicin—liver cancer	0.000123	0.00118	CcSEcCtD
Busulfan—Pancreatitis—Doxorubicin—liver cancer	0.000122	0.00118	CcSEcCtD
Busulfan—Weight decreased—Epirubicin—liver cancer	0.000122	0.00118	CcSEcCtD
Busulfan—Hyperglycaemia—Epirubicin—liver cancer	0.000122	0.00117	CcSEcCtD
Busulfan—Pneumonia—Epirubicin—liver cancer	0.000121	0.00117	CcSEcCtD
Busulfan—Infestation NOS—Epirubicin—liver cancer	0.00012	0.00116	CcSEcCtD
Busulfan—Infestation—Epirubicin—liver cancer	0.00012	0.00116	CcSEcCtD
Busulfan—Pancytopenia—Doxorubicin—liver cancer	0.000119	0.00114	CcSEcCtD
Busulfan—Renal failure—Epirubicin—liver cancer	0.000118	0.00114	CcSEcCtD
Busulfan—Stomatitis—Epirubicin—liver cancer	0.000117	0.00113	CcSEcCtD
Busulfan—Jaundice—Epirubicin—liver cancer	0.000117	0.00113	CcSEcCtD
Busulfan—Dysuria—Doxorubicin—liver cancer	0.000117	0.00113	CcSEcCtD
Busulfan—Neutropenia—Doxorubicin—liver cancer	0.000117	0.00113	CcSEcCtD
Busulfan—Haematuria—Epirubicin—liver cancer	0.000115	0.00111	CcSEcCtD
Busulfan—Hepatobiliary disease—Epirubicin—liver cancer	0.000114	0.0011	CcSEcCtD
Busulfan—Weight increased—Doxorubicin—liver cancer	0.000114	0.0011	CcSEcCtD
Busulfan—Epistaxis—Epirubicin—liver cancer	0.000113	0.00109	CcSEcCtD
Busulfan—Weight decreased—Doxorubicin—liver cancer	0.000113	0.00109	CcSEcCtD
Busulfan—Sinusitis—Epirubicin—liver cancer	0.000113	0.00109	CcSEcCtD
Busulfan—Hyperglycaemia—Doxorubicin—liver cancer	0.000113	0.00109	CcSEcCtD
Busulfan—Agranulocytosis—Epirubicin—liver cancer	0.000112	0.00108	CcSEcCtD
Busulfan—Pneumonia—Doxorubicin—liver cancer	0.000112	0.00108	CcSEcCtD
Busulfan—Infestation NOS—Doxorubicin—liver cancer	0.000111	0.00107	CcSEcCtD
Busulfan—Infestation—Doxorubicin—liver cancer	0.000111	0.00107	CcSEcCtD
Busulfan—Bradycardia—Epirubicin—liver cancer	0.00011	0.00106	CcSEcCtD
Busulfan—Renal failure—Doxorubicin—liver cancer	0.000109	0.00106	CcSEcCtD
Busulfan—Haemoglobin—Epirubicin—liver cancer	0.000109	0.00105	CcSEcCtD
Busulfan—Stomatitis—Doxorubicin—liver cancer	0.000108	0.00105	CcSEcCtD
Busulfan—Jaundice—Doxorubicin—liver cancer	0.000108	0.00105	CcSEcCtD
Busulfan—Rhinitis—Epirubicin—liver cancer	0.000108	0.00104	CcSEcCtD
Busulfan—Haemorrhage—Epirubicin—liver cancer	0.000108	0.00104	CcSEcCtD
Busulfan—Pharyngitis—Epirubicin—liver cancer	0.000107	0.00103	CcSEcCtD
Busulfan—Urinary tract disorder—Epirubicin—liver cancer	0.000107	0.00103	CcSEcCtD
Busulfan—Haematuria—Doxorubicin—liver cancer	0.000106	0.00102	CcSEcCtD
Busulfan—Connective tissue disorder—Epirubicin—liver cancer	0.000106	0.00102	CcSEcCtD
Busulfan—Urethral disorder—Epirubicin—liver cancer	0.000106	0.00102	CcSEcCtD
Busulfan—Hepatobiliary disease—Doxorubicin—liver cancer	0.000105	0.00102	CcSEcCtD
Busulfan—Epistaxis—Doxorubicin—liver cancer	0.000105	0.00101	CcSEcCtD
Busulfan—Sinusitis—Doxorubicin—liver cancer	0.000104	0.00101	CcSEcCtD
Busulfan—Agranulocytosis—Doxorubicin—liver cancer	0.000104	0.001	CcSEcCtD
Busulfan—Erythema multiforme—Epirubicin—liver cancer	0.000102	0.000985	CcSEcCtD
Busulfan—Bradycardia—Doxorubicin—liver cancer	0.000102	0.000981	CcSEcCtD
Busulfan—Eye disorder—Epirubicin—liver cancer	0.000101	0.000973	CcSEcCtD
Busulfan—Haemoglobin—Doxorubicin—liver cancer	0.0001	0.000969	CcSEcCtD
Busulfan—Flushing—Epirubicin—liver cancer	0.0001	0.000967	CcSEcCtD
Busulfan—Cardiac disorder—Epirubicin—liver cancer	0.0001	0.000967	CcSEcCtD
Busulfan—Rhinitis—Doxorubicin—liver cancer	0.0001	0.000966	CcSEcCtD
Busulfan—Haemorrhage—Doxorubicin—liver cancer	9.99e-05	0.000964	CcSEcCtD
Busulfan—Pharyngitis—Doxorubicin—liver cancer	9.92e-05	0.000956	CcSEcCtD
Busulfan—Urinary tract disorder—Doxorubicin—liver cancer	9.87e-05	0.000952	CcSEcCtD
Busulfan—Connective tissue disorder—Doxorubicin—liver cancer	9.82e-05	0.000947	CcSEcCtD
Busulfan—Angiopathy—Epirubicin—liver cancer	9.8e-05	0.000945	CcSEcCtD
Busulfan—Urethral disorder—Doxorubicin—liver cancer	9.79e-05	0.000945	CcSEcCtD
Busulfan—Immune system disorder—Epirubicin—liver cancer	9.75e-05	0.000941	CcSEcCtD
Busulfan—Mediastinal disorder—Epirubicin—liver cancer	9.73e-05	0.000939	CcSEcCtD
Busulfan—Chills—Epirubicin—liver cancer	9.69e-05	0.000934	CcSEcCtD
Busulfan—Arrhythmia—Epirubicin—liver cancer	9.65e-05	0.00093	CcSEcCtD
Busulfan—Alopecia—Epirubicin—liver cancer	9.54e-05	0.00092	CcSEcCtD
Busulfan—Mental disorder—Epirubicin—liver cancer	9.46e-05	0.000912	CcSEcCtD
Busulfan—Erythema multiforme—Doxorubicin—liver cancer	9.45e-05	0.000911	CcSEcCtD
Busulfan—Erythema—Epirubicin—liver cancer	9.4e-05	0.000907	CcSEcCtD
Busulfan—Malnutrition—Epirubicin—liver cancer	9.4e-05	0.000907	CcSEcCtD
Busulfan—Eye disorder—Doxorubicin—liver cancer	9.34e-05	0.000901	CcSEcCtD
Busulfan—Flushing—Doxorubicin—liver cancer	9.27e-05	0.000894	CcSEcCtD
Busulfan—Cardiac disorder—Doxorubicin—liver cancer	9.27e-05	0.000894	CcSEcCtD
Busulfan—Tension—Epirubicin—liver cancer	9.23e-05	0.00089	CcSEcCtD
Busulfan—Nervousness—Epirubicin—liver cancer	9.13e-05	0.000881	CcSEcCtD
Busulfan—Back pain—Epirubicin—liver cancer	9.09e-05	0.000877	CcSEcCtD
Busulfan—Angiopathy—Doxorubicin—liver cancer	9.07e-05	0.000874	CcSEcCtD
Busulfan—Immune system disorder—Doxorubicin—liver cancer	9.03e-05	0.00087	CcSEcCtD
Busulfan—Mediastinal disorder—Doxorubicin—liver cancer	9.01e-05	0.000868	CcSEcCtD
Busulfan—Chills—Doxorubicin—liver cancer	8.97e-05	0.000865	CcSEcCtD
Busulfan—Arrhythmia—Doxorubicin—liver cancer	8.93e-05	0.000861	CcSEcCtD
Busulfan—Alopecia—Doxorubicin—liver cancer	8.83e-05	0.000852	CcSEcCtD
Busulfan—Mental disorder—Doxorubicin—liver cancer	8.75e-05	0.000844	CcSEcCtD
Busulfan—Malnutrition—Doxorubicin—liver cancer	8.7e-05	0.000839	CcSEcCtD
Busulfan—Erythema—Doxorubicin—liver cancer	8.7e-05	0.000839	CcSEcCtD
Busulfan—Anaemia—Epirubicin—liver cancer	8.69e-05	0.000838	CcSEcCtD
Busulfan—Agitation—Epirubicin—liver cancer	8.64e-05	0.000833	CcSEcCtD
Busulfan—Tension—Doxorubicin—liver cancer	8.54e-05	0.000823	CcSEcCtD
Busulfan—Nervousness—Doxorubicin—liver cancer	8.45e-05	0.000815	CcSEcCtD
Busulfan—Leukopenia—Epirubicin—liver cancer	8.41e-05	0.000812	CcSEcCtD
Busulfan—Back pain—Doxorubicin—liver cancer	8.41e-05	0.000811	CcSEcCtD
Busulfan—Cough—Epirubicin—liver cancer	8.2e-05	0.000791	CcSEcCtD
Busulfan—MGST2—Metabolism—NR1H4—liver cancer	8.18e-05	0.000644	CbGpPWpGaD
Busulfan—Convulsion—Epirubicin—liver cancer	8.15e-05	0.000786	CcSEcCtD
Busulfan—Hypertension—Epirubicin—liver cancer	8.12e-05	0.000783	CcSEcCtD
Busulfan—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	8.1e-05	0.000637	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—UGDH—liver cancer	8.04e-05	0.000633	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GSTA3—liver cancer	8.04e-05	0.000633	CbGpPWpGaD
Busulfan—Anaemia—Doxorubicin—liver cancer	8.04e-05	0.000775	CcSEcCtD
Busulfan—Myalgia—Epirubicin—liver cancer	8e-05	0.000772	CcSEcCtD
Busulfan—Arthralgia—Epirubicin—liver cancer	8e-05	0.000772	CcSEcCtD
Busulfan—Chest pain—Epirubicin—liver cancer	8e-05	0.000772	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—MYC—liver cancer	8e-05	0.00063	CbGpPWpGaD
Busulfan—Agitation—Doxorubicin—liver cancer	7.99e-05	0.000771	CcSEcCtD
Busulfan—Anxiety—Epirubicin—liver cancer	7.98e-05	0.000769	CcSEcCtD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	7.95e-05	0.000767	CcSEcCtD
Busulfan—Dry mouth—Epirubicin—liver cancer	7.83e-05	0.000755	CcSEcCtD
Busulfan—GSTM1—Metabolism—UGDH—liver cancer	7.82e-05	0.000616	CbGpPWpGaD
Busulfan—GSTA1—NRF2 pathway—TGFB1—liver cancer	7.8e-05	0.000614	CbGpPWpGaD
Busulfan—Leukopenia—Doxorubicin—liver cancer	7.79e-05	0.000751	CcSEcCtD
Busulfan—Confusional state—Epirubicin—liver cancer	7.74e-05	0.000746	CcSEcCtD
Busulfan—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	7.68e-05	0.000604	CbGpPWpGaD
Busulfan—Oedema—Epirubicin—liver cancer	7.67e-05	0.00074	CcSEcCtD
Busulfan—Infection—Epirubicin—liver cancer	7.62e-05	0.000735	CcSEcCtD
Busulfan—Cough—Doxorubicin—liver cancer	7.59e-05	0.000732	CcSEcCtD
Busulfan—GSTA2—Metabolism—EPT1—liver cancer	7.56e-05	0.000595	CbGpPWpGaD
Busulfan—Convulsion—Doxorubicin—liver cancer	7.54e-05	0.000727	CcSEcCtD
Busulfan—Nervous system disorder—Epirubicin—liver cancer	7.52e-05	0.000726	CcSEcCtD
Busulfan—Thrombocytopenia—Epirubicin—liver cancer	7.51e-05	0.000724	CcSEcCtD
Busulfan—Hypertension—Doxorubicin—liver cancer	7.51e-05	0.000724	CcSEcCtD
Busulfan—Tachycardia—Epirubicin—liver cancer	7.49e-05	0.000722	CcSEcCtD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	7.49e-05	0.000589	CbGpPWpGaD
Busulfan—Skin disorder—Epirubicin—liver cancer	7.45e-05	0.000719	CcSEcCtD
Busulfan—Myalgia—Doxorubicin—liver cancer	7.41e-05	0.000714	CcSEcCtD
Busulfan—Arthralgia—Doxorubicin—liver cancer	7.41e-05	0.000714	CcSEcCtD
Busulfan—Chest pain—Doxorubicin—liver cancer	7.41e-05	0.000714	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—KRAS—liver cancer	7.39e-05	0.000582	CbGpPWpGaD
Busulfan—Anxiety—Doxorubicin—liver cancer	7.38e-05	0.000712	CcSEcCtD
Busulfan—MGST2—Metabolism—GSTA4—liver cancer	7.36e-05	0.000579	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—EPT1—liver cancer	7.36e-05	0.000579	CbGpPWpGaD
Busulfan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	7.35e-05	0.000709	CcSEcCtD
Busulfan—CYP3A4—Irinotecan Pathway—APC—liver cancer	7.35e-05	0.000579	CbGpPWpGaD
Busulfan—Anorexia—Epirubicin—liver cancer	7.31e-05	0.000705	CcSEcCtD
Busulfan—Dry mouth—Doxorubicin—liver cancer	7.24e-05	0.000698	CcSEcCtD
Busulfan—GSTA1—Metabolism—CPT1B—liver cancer	7.21e-05	0.000568	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—GLUL—liver cancer	7.21e-05	0.000568	CbGpPWpGaD
Busulfan—Hypotension—Epirubicin—liver cancer	7.17e-05	0.000691	CcSEcCtD
Busulfan—GSTA2—Metabolism—TAT—liver cancer	7.17e-05	0.000564	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GSTA2—liver cancer	7.17e-05	0.000564	CbGpPWpGaD
Busulfan—Confusional state—Doxorubicin—liver cancer	7.16e-05	0.00069	CcSEcCtD
Busulfan—Oedema—Doxorubicin—liver cancer	7.1e-05	0.000685	CcSEcCtD
Busulfan—CYP3A4—Xenobiotics—CYP1A1—liver cancer	7.06e-05	0.000555	CbGpPWpGaD
Busulfan—Infection—Doxorubicin—liver cancer	7.05e-05	0.00068	CcSEcCtD
Busulfan—Musculoskeletal discomfort—Epirubicin—liver cancer	6.99e-05	0.000674	CcSEcCtD
Busulfan—GSTM1—Metabolism—TAT—liver cancer	6.97e-05	0.000549	CbGpPWpGaD
Busulfan—Nervous system disorder—Doxorubicin—liver cancer	6.96e-05	0.000671	CcSEcCtD
Busulfan—GSTA1—Metabolism—NR1H4—liver cancer	6.96e-05	0.000547	CbGpPWpGaD
Busulfan—Thrombocytopenia—Doxorubicin—liver cancer	6.95e-05	0.00067	CcSEcCtD
Busulfan—Insomnia—Epirubicin—liver cancer	6.94e-05	0.000669	CcSEcCtD
Busulfan—Tachycardia—Doxorubicin—liver cancer	6.93e-05	0.000668	CcSEcCtD
Busulfan—MGST2—Metabolism—GSTA1—liver cancer	6.92e-05	0.000544	CbGpPWpGaD
Busulfan—Skin disorder—Doxorubicin—liver cancer	6.9e-05	0.000665	CcSEcCtD
Busulfan—Dyspnoea—Epirubicin—liver cancer	6.84e-05	0.00066	CcSEcCtD
Busulfan—GSTA1—Metabolism—GSTA3—liver cancer	6.84e-05	0.000538	CbGpPWpGaD
Busulfan—MGST2—Metabolism—NAT2—liver cancer	6.84e-05	0.000538	CbGpPWpGaD
Busulfan—Somnolence—Epirubicin—liver cancer	6.82e-05	0.000658	CcSEcCtD
Busulfan—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	6.79e-05	0.000534	CbGpPWpGaD
Busulfan—Anorexia—Doxorubicin—liver cancer	6.77e-05	0.000653	CcSEcCtD
Busulfan—Dyspepsia—Epirubicin—liver cancer	6.75e-05	0.000651	CcSEcCtD
Busulfan—Decreased appetite—Epirubicin—liver cancer	6.67e-05	0.000643	CcSEcCtD
Busulfan—GSTP1—Metabolism—UGDH—liver cancer	6.65e-05	0.000524	CbGpPWpGaD
Busulfan—Hypotension—Doxorubicin—liver cancer	6.63e-05	0.00064	CcSEcCtD
Busulfan—Gastrointestinal disorder—Epirubicin—liver cancer	6.62e-05	0.000639	CcSEcCtD
Busulfan—Fatigue—Epirubicin—liver cancer	6.61e-05	0.000638	CcSEcCtD
Busulfan—Constipation—Epirubicin—liver cancer	6.56e-05	0.000633	CcSEcCtD
Busulfan—Pain—Epirubicin—liver cancer	6.56e-05	0.000633	CcSEcCtD
Busulfan—MGST2—Metabolism—ALDOB—liver cancer	6.56e-05	0.000516	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—H2AFX—liver cancer	6.49e-05	0.000511	CbGpPWpGaD
Busulfan—Musculoskeletal discomfort—Doxorubicin—liver cancer	6.47e-05	0.000624	CcSEcCtD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	6.43e-05	0.000506	CbGpPWpGaD
Busulfan—Insomnia—Doxorubicin—liver cancer	6.42e-05	0.000619	CcSEcCtD
Busulfan—Dyspnoea—Doxorubicin—liver cancer	6.33e-05	0.00061	CcSEcCtD
Busulfan—Feeling abnormal—Epirubicin—liver cancer	6.32e-05	0.00061	CcSEcCtD
Busulfan—Somnolence—Doxorubicin—liver cancer	6.31e-05	0.000609	CcSEcCtD
Busulfan—GSTM1—C-MYB transcription factor network—HRAS—liver cancer	6.28e-05	0.000494	CbGpPWpGaD
Busulfan—Gastrointestinal pain—Epirubicin—liver cancer	6.27e-05	0.000605	CcSEcCtD
Busulfan—GSTP1—Metabolism—EPT1—liver cancer	6.25e-05	0.000492	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—GSTA4—liver cancer	6.25e-05	0.000492	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CRABP1—liver cancer	6.25e-05	0.000492	CbGpPWpGaD
Busulfan—Dyspepsia—Doxorubicin—liver cancer	6.25e-05	0.000603	CcSEcCtD
Busulfan—Decreased appetite—Doxorubicin—liver cancer	6.17e-05	0.000595	CcSEcCtD
Busulfan—Gastrointestinal disorder—Doxorubicin—liver cancer	6.13e-05	0.000591	CcSEcCtD
Busulfan—Fatigue—Doxorubicin—liver cancer	6.12e-05	0.00059	CcSEcCtD
Busulfan—Urticaria—Epirubicin—liver cancer	6.1e-05	0.000588	CcSEcCtD
Busulfan—GSTA1—Metabolism—GSTA2—liver cancer	6.09e-05	0.00048	CbGpPWpGaD
Busulfan—Constipation—Doxorubicin—liver cancer	6.07e-05	0.000585	CcSEcCtD
Busulfan—Pain—Doxorubicin—liver cancer	6.07e-05	0.000585	CcSEcCtD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	6.07e-05	0.000478	CbGpPWpGaD
Busulfan—Body temperature increased—Epirubicin—liver cancer	6.07e-05	0.000585	CcSEcCtD
Busulfan—Abdominal pain—Epirubicin—liver cancer	6.07e-05	0.000585	CcSEcCtD
Busulfan—GSTP1—Metabolism—TAT—liver cancer	5.93e-05	0.000467	CbGpPWpGaD
Busulfan—Feeling abnormal—Doxorubicin—liver cancer	5.85e-05	0.000564	CcSEcCtD
Busulfan—GSTA1—Metabolism—NAT2—liver cancer	5.81e-05	0.000458	CbGpPWpGaD
Busulfan—Gastrointestinal pain—Doxorubicin—liver cancer	5.81e-05	0.00056	CcSEcCtD
Busulfan—Hypersensitivity—Epirubicin—liver cancer	5.65e-05	0.000545	CcSEcCtD
Busulfan—Urticaria—Doxorubicin—liver cancer	5.64e-05	0.000544	CcSEcCtD
Busulfan—Abdominal pain—Doxorubicin—liver cancer	5.61e-05	0.000541	CcSEcCtD
Busulfan—Body temperature increased—Doxorubicin—liver cancer	5.61e-05	0.000541	CcSEcCtD
Busulfan—GSTA1—Metabolism—ALDOB—liver cancer	5.57e-05	0.000439	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—UGDH—liver cancer	5.52e-05	0.000434	CbGpPWpGaD
Busulfan—Asthenia—Epirubicin—liver cancer	5.5e-05	0.000531	CcSEcCtD
Busulfan—MGST2—Metabolism—HPGDS—liver cancer	5.47e-05	0.00043	CbGpPWpGaD
Busulfan—Pruritus—Epirubicin—liver cancer	5.43e-05	0.000523	CcSEcCtD
Busulfan—GSTP1—Cellular responses to stress—MAPK14—liver cancer	5.33e-05	0.00042	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CRABP1—liver cancer	5.32e-05	0.000419	CbGpPWpGaD
Busulfan—GSTA2—NRF2 pathway—TGFB1—liver cancer	5.27e-05	0.000415	CbGpPWpGaD
Busulfan—Diarrhoea—Epirubicin—liver cancer	5.25e-05	0.000506	CcSEcCtD
Busulfan—Hypersensitivity—Doxorubicin—liver cancer	5.23e-05	0.000504	CcSEcCtD
Busulfan—GSTM1—NRF2 pathway—TGFB1—liver cancer	5.13e-05	0.000404	CbGpPWpGaD
Busulfan—Asthenia—Doxorubicin—liver cancer	5.09e-05	0.000491	CcSEcCtD
Busulfan—Dizziness—Epirubicin—liver cancer	5.07e-05	0.000489	CcSEcCtD
Busulfan—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	5.04e-05	0.000397	CbGpPWpGaD
Busulfan—Pruritus—Doxorubicin—liver cancer	5.02e-05	0.000484	CcSEcCtD
Busulfan—Vomiting—Epirubicin—liver cancer	4.88e-05	0.00047	CcSEcCtD
Busulfan—GSTA2—Metabolism—GLUL—liver cancer	4.87e-05	0.000383	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CPT1B—liver cancer	4.87e-05	0.000383	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PSMD10—liver cancer	4.87e-05	0.000383	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PSMA4—liver cancer	4.87e-05	0.000383	CbGpPWpGaD
Busulfan—Diarrhoea—Doxorubicin—liver cancer	4.86e-05	0.000468	CcSEcCtD
Busulfan—Rash—Epirubicin—liver cancer	4.84e-05	0.000467	CcSEcCtD
Busulfan—Dermatitis—Epirubicin—liver cancer	4.83e-05	0.000466	CcSEcCtD
Busulfan—Headache—Epirubicin—liver cancer	4.81e-05	0.000464	CcSEcCtD
Busulfan—MGST2—Metabolism—GOT2—liver cancer	4.74e-05	0.000373	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CPT1B—liver cancer	4.74e-05	0.000373	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GLUL—liver cancer	4.74e-05	0.000373	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—NR1H4—liver cancer	4.7e-05	0.00037	CbGpPWpGaD
Busulfan—Dizziness—Doxorubicin—liver cancer	4.69e-05	0.000453	CcSEcCtD
Busulfan—GSTA1—Metabolism—HPGDS—liver cancer	4.65e-05	0.000366	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GSTA3—liver cancer	4.62e-05	0.000364	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—NR1H4—liver cancer	4.57e-05	0.00036	CbGpPWpGaD
Busulfan—Nausea—Epirubicin—liver cancer	4.56e-05	0.00044	CcSEcCtD
Busulfan—Vomiting—Doxorubicin—liver cancer	4.51e-05	0.000435	CcSEcCtD
Busulfan—GSTM1—Metabolism—GSTA3—liver cancer	4.49e-05	0.000354	CbGpPWpGaD
Busulfan—Rash—Doxorubicin—liver cancer	4.48e-05	0.000432	CcSEcCtD
Busulfan—Dermatitis—Doxorubicin—liver cancer	4.47e-05	0.000431	CcSEcCtD
Busulfan—MGST2—Metabolism—CYP2E1—liver cancer	4.46e-05	0.000351	CbGpPWpGaD
Busulfan—Headache—Doxorubicin—liver cancer	4.45e-05	0.000429	CcSEcCtD
Busulfan—GSTP1—NRF2 pathway—TGFB1—liver cancer	4.36e-05	0.000343	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GSTA4—liver cancer	4.22e-05	0.000333	CbGpPWpGaD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	4.22e-05	0.000332	CbGpPWpGaD
Busulfan—Nausea—Doxorubicin—liver cancer	4.22e-05	0.000407	CcSEcCtD
Busulfan—MGST2—Metabolism—CYCS—liver cancer	4.17e-05	0.000328	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PSMA4—liver cancer	4.14e-05	0.000326	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PSMD10—liver cancer	4.14e-05	0.000326	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GSTA4—liver cancer	4.11e-05	0.000323	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GGT1—liver cancer	4.09e-05	0.000322	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GOT1—liver cancer	4.09e-05	0.000322	CbGpPWpGaD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	4.08e-05	0.000321	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—GOT2—liver cancer	4.03e-05	0.000317	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CPT1B—liver cancer	4.03e-05	0.000317	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GLUL—liver cancer	4.03e-05	0.000317	CbGpPWpGaD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	4.03e-05	0.000317	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—CDKN2A—liver cancer	4.01e-05	0.000316	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GSTA2—liver cancer	4e-05	0.000315	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GSTA1—liver cancer	3.97e-05	0.000313	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—NAT2—liver cancer	3.93e-05	0.000309	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—NR1H4—liver cancer	3.89e-05	0.000306	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GSTA1—liver cancer	3.86e-05	0.000304	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—NAT2—liver cancer	3.82e-05	0.000301	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTA3—liver cancer	3.82e-05	0.000301	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CYP2E1—liver cancer	3.79e-05	0.000298	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—MTOR—liver cancer	3.79e-05	0.000298	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ALDOB—liver cancer	3.77e-05	0.000296	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GSTP1—liver cancer	3.68e-05	0.000289	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ALDOB—liver cancer	3.66e-05	0.000288	CbGpPWpGaD
Busulfan—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	3.62e-05	0.000285	CbGpPWpGaD
Busulfan—MGST2—Metabolism—HMOX1—liver cancer	3.62e-05	0.000285	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CRABP1—liver cancer	3.59e-05	0.000283	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—CDKN1B—liver cancer	3.56e-05	0.00028	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CYCS—liver cancer	3.55e-05	0.000279	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CRABP1—liver cancer	3.49e-05	0.000275	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTA4—liver cancer	3.49e-05	0.000275	CbGpPWpGaD
Busulfan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	3.49e-05	0.000275	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—GGT1—liver cancer	3.48e-05	0.000274	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—GOT1—liver cancer	3.48e-05	0.000274	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTA2—liver cancer	3.41e-05	0.000268	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—JUN—liver cancer	3.38e-05	0.000266	CbGpPWpGaD
Busulfan—MGST2—Metabolism—GSTM1—liver cancer	3.38e-05	0.000266	CbGpPWpGaD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	3.31e-05	0.00026	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTA1—liver cancer	3.29e-05	0.000259	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—CDKN1A—liver cancer	3.28e-05	0.000258	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—NAT2—liver cancer	3.25e-05	0.000256	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—NR1H4—liver cancer	3.22e-05	0.000254	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—MAPK8—liver cancer	3.2e-05	0.000252	CbGpPWpGaD
Busulfan—MGST2—Metabolism—CYP1A1—liver cancer	3.2e-05	0.000252	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTA3—liver cancer	3.17e-05	0.000249	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—HPGDS—liver cancer	3.14e-05	0.000247	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	3.13e-05	0.000246	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—GSTP1—liver cancer	3.12e-05	0.000246	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ALDOB—liver cancer	3.11e-05	0.000245	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—HMOX1—liver cancer	3.08e-05	0.000243	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—HPGDS—liver cancer	3.05e-05	0.00024	CbGpPWpGaD
Busulfan—MGST2—Metabolism—MTHFR—liver cancer	2.98e-05	0.000235	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CRABP1—liver cancer	2.97e-05	0.000234	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—VEGFA—liver cancer	2.96e-05	0.000233	CbGpPWpGaD
Busulfan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	2.93e-05	0.000231	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PPARA—liver cancer	2.93e-05	0.00023	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—STAT3—liver cancer	2.93e-05	0.00023	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTA4—liver cancer	2.9e-05	0.000228	CbGpPWpGaD
Busulfan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	2.89e-05	0.000228	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—GSTM1—liver cancer	2.87e-05	0.000226	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	2.86e-05	0.000225	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTA2—liver cancer	2.83e-05	0.000222	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PSMA4—liver cancer	2.8e-05	0.00022	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PSMD10—liver cancer	2.8e-05	0.00022	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTA1—liver cancer	2.73e-05	0.000215	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GOT2—liver cancer	2.72e-05	0.000214	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PSMD10—liver cancer	2.72e-05	0.000214	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—CYP1A1—liver cancer	2.72e-05	0.000214	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PSMA4—liver cancer	2.72e-05	0.000214	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—NAT2—liver cancer	2.7e-05	0.000212	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	2.66e-05	0.000209	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GOT2—liver cancer	2.65e-05	0.000208	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—HPGDS—liver cancer	2.6e-05	0.000204	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CYP2E1—liver cancer	2.56e-05	0.000201	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—MTHFR—liver cancer	2.54e-05	0.0002	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PIK3CG—liver cancer	2.51e-05	0.000197	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP2E1—liver cancer	2.49e-05	0.000196	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PPARA—liver cancer	2.49e-05	0.000196	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PPARG—liver cancer	2.42e-05	0.00019	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CYCS—liver cancer	2.39e-05	0.000188	CbGpPWpGaD
Busulfan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	2.38e-05	0.000187	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GGT1—liver cancer	2.35e-05	0.000185	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GOT1—liver cancer	2.35e-05	0.000185	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYCS—liver cancer	2.33e-05	0.000183	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PSMA4—liver cancer	2.31e-05	0.000182	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PSMD10—liver cancer	2.31e-05	0.000182	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GOT1—liver cancer	2.29e-05	0.00018	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GGT1—liver cancer	2.29e-05	0.00018	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	2.26e-05	0.000178	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GOT2—liver cancer	2.25e-05	0.000177	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—TP53—liver cancer	2.23e-05	0.000176	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PIK3CD—liver cancer	2.2e-05	0.000174	CbGpPWpGaD
Busulfan—MGST2—Metabolism—ALB—liver cancer	2.18e-05	0.000171	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—HPGDS—liver cancer	2.15e-05	0.00017	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CG—liver cancer	2.13e-05	0.000168	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP2E1—liver cancer	2.12e-05	0.000167	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GSTP1—liver cancer	2.11e-05	0.000166	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—HMOX1—liver cancer	2.08e-05	0.000164	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PPARG—liver cancer	2.06e-05	0.000162	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—GSTP1—liver cancer	2.05e-05	0.000162	CbGpPWpGaD
Busulfan—GSTP1—Cellular responses to stress—IL6—liver cancer	2.05e-05	0.000161	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—HMOX1—liver cancer	2.03e-05	0.000159	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYCS—liver cancer	1.98e-05	0.000156	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GOT1—liver cancer	1.94e-05	0.000153	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GGT1—liver cancer	1.94e-05	0.000153	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—GSTM1—liver cancer	1.94e-05	0.000153	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PIK3CB—liver cancer	1.92e-05	0.000151	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CD—liver cancer	1.87e-05	0.000148	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—ALB—liver cancer	1.85e-05	0.000146	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—CYP1A1—liver cancer	1.84e-05	0.000145	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—CYP1A1—liver cancer	1.79e-05	0.000141	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—CYP2E1—liver cancer	1.76e-05	0.000138	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	1.73e-05	0.000136	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—HMOX1—liver cancer	1.72e-05	0.000136	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—MTHFR—liver cancer	1.71e-05	0.000135	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PPARA—liver cancer	1.68e-05	0.000132	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—MTHFR—liver cancer	1.67e-05	0.000131	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PPARA—liver cancer	1.64e-05	0.000129	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CB—liver cancer	1.63e-05	0.000129	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GGT1—liver cancer	1.61e-05	0.000127	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—GSTM1—liver cancer	1.6e-05	0.000126	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—CYP1A1—liver cancer	1.52e-05	0.00012	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTP1—liver cancer	1.45e-05	0.000114	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CG—liver cancer	1.44e-05	0.000113	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	1.43e-05	0.000112	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—MTHFR—liver cancer	1.42e-05	0.000112	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CG—liver cancer	1.4e-05	0.00011	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PPARA—liver cancer	1.39e-05	0.000109	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PPARG—liver cancer	1.39e-05	0.000109	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PPARG—liver cancer	1.35e-05	0.000106	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—GSTM1—liver cancer	1.33e-05	0.000105	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	1.31e-05	0.000103	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CD—liver cancer	1.27e-05	9.97e-05	CbGpPWpGaD
Busulfan—CYP3A4—Biological oxidations—CYP1A1—liver cancer	1.26e-05	9.93e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—ALB—liver cancer	1.25e-05	9.84e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	1.24e-05	9.8e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CD—liver cancer	1.23e-05	9.69e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—ALB—liver cancer	1.22e-05	9.57e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CG—liver cancer	1.19e-05	9.38e-05	CbGpPWpGaD
Busulfan—MGST2—Metabolism—PIK3CA—liver cancer	1.17e-05	9.22e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PPARG—liver cancer	1.15e-05	9.05e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CB—liver cancer	1.1e-05	8.69e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CB—liver cancer	1.07e-05	8.45e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CD—liver cancer	1.05e-05	8.24e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—ALB—liver cancer	1.03e-05	8.14e-05	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—PIK3CA—liver cancer	9.96e-06	7.84e-05	CbGpPWpGaD
Busulfan—MGST2—Metabolism—AKT1—liver cancer	9.57e-06	7.53e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—UGDH—liver cancer	9.44e-06	7.43e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CB—liver cancer	9.13e-06	7.18e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—EPT1—liver cancer	8.87e-06	6.98e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—TAT—liver cancer	8.41e-06	6.62e-05	CbGpPWpGaD
Busulfan—GSTA1—Metabolism—AKT1—liver cancer	8.14e-06	6.4e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—PIK3CA—liver cancer	6.73e-06	5.3e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—PIK3CA—liver cancer	6.54e-06	5.15e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GLUL—liver cancer	5.72e-06	4.5e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CPT1B—liver cancer	5.72e-06	4.5e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—PIK3CA—liver cancer	5.56e-06	4.38e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NR1H4—liver cancer	5.51e-06	4.34e-05	CbGpPWpGaD
Busulfan—GSTA2—Metabolism—AKT1—liver cancer	5.5e-06	4.33e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTA3—liver cancer	5.42e-06	4.27e-05	CbGpPWpGaD
Busulfan—GSTM1—Metabolism—AKT1—liver cancer	5.35e-06	4.21e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTA4—liver cancer	4.96e-06	3.9e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTA2—liver cancer	4.83e-06	3.8e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTA1—liver cancer	4.66e-06	3.67e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—NAT2—liver cancer	4.61e-06	3.63e-05	CbGpPWpGaD
Busulfan—GSTP1—Metabolism—AKT1—liver cancer	4.55e-06	3.58e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ALDOB—liver cancer	4.42e-06	3.48e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CRABP1—liver cancer	4.22e-06	3.32e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—HPGDS—liver cancer	3.68e-06	2.9e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PSMA4—liver cancer	3.28e-06	2.58e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PSMD10—liver cancer	3.28e-06	2.58e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GOT2—liver cancer	3.19e-06	2.51e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP2E1—liver cancer	3e-06	2.36e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYCS—liver cancer	2.81e-06	2.21e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GOT1—liver cancer	2.76e-06	2.17e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GGT1—liver cancer	2.76e-06	2.17e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTP1—liver cancer	2.48e-06	1.95e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—HMOX1—liver cancer	2.44e-06	1.92e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—GSTM1—liver cancer	2.28e-06	1.79e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—CYP1A1—liver cancer	2.16e-06	1.7e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—MTHFR—liver cancer	2.01e-06	1.58e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PPARA—liver cancer	1.97e-06	1.55e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CG—liver cancer	1.69e-06	1.33e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PPARG—liver cancer	1.63e-06	1.28e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CD—liver cancer	1.49e-06	1.17e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—ALB—liver cancer	1.47e-06	1.15e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CB—liver cancer	1.3e-06	1.02e-05	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—PIK3CA—liver cancer	7.9e-07	6.21e-06	CbGpPWpGaD
Busulfan—CYP3A4—Metabolism—AKT1—liver cancer	6.45e-07	5.08e-06	CbGpPWpGaD
